Siefert H M, Maruhn D, Scholl H
Arzneimittelforschung. 1986 Oct;36(10):1503-10.
1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-[U-14C]piperazinyl)-3-quinoline carboxylic acid (ciprofloxacin, Bay o 9867; designated tradename: Ciprobay) was administered to male and to pregnant albino rats with single intravenous or oral doses of 5 or 10 mg/kg body weight and with repeated oral doses of 5 mg/kg (7 consecutive daily administrations to male rats). Following a single intravenous administration the [14C]ciprofloxacin related radioactivity was distributed rapidly and differentiated to the body. Compared to plasma high concentrations were determined in kidney, liver, skeleton muscle, pancreas, testes and cartilage, low concentrations occurred in brain and adipose tissue. In some selected tissues radioactivity was largely due to unchanged [14C]ciprofloxacin (57% to 100%). A good penetration of total radioactivity into tissues and organs with a similar distribution pattern as detected after intravenous dosing also occurred after a single oral administration. Highest concentrations were determined 1 h after dosing. Compared to plasma most tissues and organs showed higher concentrations and higher AUC-values. For brain and eye low values were determined. Compared to plasma a longer mean residence time of radioactivity was calculated for brain, eye, eye-wall, testes and blood cells. 6 d after single administration the radioactive residues in the body exclusive gastrointestinal tract amounted to less than 0.1% of the dose. Following a seven-day treatment the distribution pattern of total radioactivity in the body did not differ essentially from that after single dosing. Compared to single dosing AUC-values higher by the factor 2 to 4 were calculated after repeated administration for plasma and most of the tissues and organs.(ABSTRACT TRUNCATED AT 250 WORDS)
1-环丙基-6-氟-1,4-二氢-4-氧代-7-(1-[U-14C]哌嗪基)-3-喹啉羧酸(环丙沙星,拜耳O 9867;商品名:拜复乐)以5或10毫克/千克体重的单次静脉内或口服剂量给予雄性和怀孕白化大鼠,并以5毫克/千克的重复口服剂量(对雄性大鼠连续7天每日给药)给药。单次静脉内给药后,[14C]环丙沙星相关放射性迅速分布并在体内分化。与血浆相比,在肾脏、肝脏、骨骼肌、胰腺、睾丸和软骨中测定到高浓度,在脑和脂肪组织中浓度较低。在一些选定组织中,放射性很大程度上归因于未变化的[14C]环丙沙星(57%至100%)。单次口服给药后,总放射性也能很好地渗透到组织和器官中,其分布模式与静脉给药后检测到的相似。给药后1小时测定到最高浓度。与血浆相比,大多数组织和器官显示出更高的浓度和更高的AUC值。脑和眼的值较低。与血浆相比,计算出脑、眼、眼壁、睾丸和血细胞中放射性的平均停留时间更长。单次给药6天后,体内(不包括胃肠道)的放射性残留量不到剂量的0.1%。经过7天治疗后,体内总放射性的分布模式与单次给药后基本没有差异。与单次给药相比,重复给药后血浆以及大多数组织和器官的AUC值高出2至4倍。(摘要截短至250字)